Atomera (ATOM)
NASDAQ:ATOM
ATOM Stock Chart & Stats
$5.09
-$3.56(-21.92%)
At close: 4:00 PM EST
$5.09
-$3.56(-21.92%)
Day’s Range― - ―
52-Week Range$1.89 - $7.73
Previous CloseN/A
Volume1.24M
Average Volume (3M)464.54K
Market Cap
$197.10M
Enterprise Value$148.21M
Total Cash (Recent Filing)$19.21M
Total Debt (Recent Filing)$1.99M
Price to Earnings (P/E)―
Beta1.84
Next Earnings
Apr 29, 2026EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding38,722,970
10 Day Avg. Volume463,975
30 Day Avg. Volume464,540
Financial Highlights & Ratios
PEG Ratio0.77
Price to Book (P/B)3.71
Price to Sales (P/S)1048.70
P/FCF Ratio-4.58
Enterprise Value/Market Cap0.75
Enterprise Value/Revenue2.28K
Enterprise Value/Gross Profit-249.09
Enterprise Value/Ebitda-7.62
Forecast
1Y Price Target
$7.00Price Target Upside37.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.54
Revenue Forecast (FY)$400.00K
Bulls Say, Bears Say
Bulls Say
GAA Technical ValidationDefinitive GAA silicon results demonstrate MST integration with nanosheet GAA structures, materially improving technical credibility for advanced-node logic. This reduces fundamental integration risk with leading fabs and increases the likelihood of multi-node licensing and long-term royalty streams once customers qualify.
OEM Equipment PartnershipA strategic equipment OEM partnership creates an industry channel to accelerate customer trials and lower adoption friction. OEM influence over fab tool flows can embed MST into customers' validation paths, shortening qualification timelines and improving the odds of scaled licensing across multiple fabs and nodes.
GaN Commercialization & FundingHaving a commercial GaN customer and a government-funded Power America proposal expands MST addressable markets into power and RF, diversifying potential revenue. External development funding reduces Atomera's R&D burden, signals strategic relevance, and improves the structural likelihood of adoption in new, large end markets.
Bears Say
Very Low Revenue Base2025 revenue of roughly $65k vs. a multi‑million dollar cost base confirms Atomera is essentially pre‑commercial. The licensing model requires conversion from evaluation to production; absent consistent production licenses, revenue will remain volatile and insufficient to cover structural operating costs, prolonging losses.
Persistent Cash BurnOperating cash use near $15M in 2025 and a cash decline to ~$19.2M indicate limited runway without further funding. Repeated equity raises (ATM sales and recent registered offering) provide liquidity but are dilutive. Continued negative FCF creates structural funding risk that can interrupt R&D and commercialization efforts.
Partner Dependence & TimingCommercialization relies heavily on foundries, OEMs and partners to run long customer test cycles (typically 6–9 months). A prior partner setback underscores execution risk: partner dependency can delay or block production adoption, making revenue timing uncertain even with positive technical results.
Atomera News
ATOM FAQ
What was Atomera’s price range in the past 12 months?
Atomera lowest stock price was $1.89 and its highest was $7.73 in the past 12 months.
What is Atomera’s market cap?
Atomera’s market cap is $197.10M.
When is Atomera’s upcoming earnings report date?
Atomera’s upcoming earnings report date is Apr 29, 2026 which is in 18 days.
How were Atomera’s earnings last quarter?
Atomera released its earnings results on Feb 12, 2026. The company reported -$0.14 earnings per share for the quarter, the consensus estimate of -$0.14 by $0.
Is Atomera overvalued?
According to Wall Street analysts Atomera’s price is currently Undervalued.
Does Atomera pay dividends?
Atomera does not currently pay dividends.
What is Atomera’s EPS estimate?
Atomera’s EPS estimate is -0.13.
How many shares outstanding does Atomera have?
Atomera has 38,722,970 shares outstanding.
What happened to Atomera’s price movement after its last earnings report?
Atomera reported an EPS of -$0.14 in its last earnings report, expectations of -$0.14. Following the earnings report the stock price went up 64.017%.
Which hedge fund is a major shareholder of Atomera?
Currently, no hedge funds are holding shares in ATOM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Atomera Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (37.52% Upside)
$7.00 (37.52% Upside)
Insider Transactions
Sold Shares
Worth $158.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 1.3%
Last 30 Days ▲ 1.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
28.12%
12-Months-Change
Fundamentals
Return on Equity
-116.86%
Trailing 12-Months
Asset Growth
10.13%
Trailing 12-Months
Company Description
Atomera
Atomera Incorporated develops, commercializes, and licenses proprietary materials, processes, and technologies for the semiconductor industry in North America and the Asia Pacific. The company's lead technology is the Mears Silicon Technology, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors. Its customers include foundries, integrated device manufacturers, fabless semiconductor manufacturers, original equipment manufacturers, and electronic design automation companies. The company was formerly known as Mears Technologies, Inc. and changed its name to Atomera Incorporated in January 2016. Atomera Incorporated was incorporated in 2001 and is headquartered in Los Gatos, California.
ATOM Company Deck
ATOM Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted substantial and potentially high-value technical progress across multiple high-growth semiconductor markets—most notably definitive GAA silicon results, active wafer runs, a commercial GaN customer and a strategic OEM partnership. However, these technical advancements have yet to translate into meaningful revenue; the company remains pre-revenue on a commercial scale, reported ongoing net losses, experienced a material cash decline in 2025, and relied on dilutive equity financings. Commercial adoption timelines remain uncertain (6–9 month test cycles and customer validation), and 2026 expense accretion tied to bonus accruals will require achieving aggressive milestones. Overall, the technical momentum is strong but balanced by near-term financial and execution risks.View all ATOM earnings summariesATOM Stock 12 Month Forecast
Average Price Target
$7.00
▲(37.52% Upside)
Technical Analysis
Amtech Systems
―
AXT
―
Sequans Communications S A
―
Everspin Technologies
―
WISeKey International Holding
―
Ownership Overview
5.43% Insiders
5.81% Mutual Funds
7.59% Other Institutional Investors
74.59% Public Companies and
Individual Investors